CAPITAL FUND MANAGEMENT S.A. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPITAL FUND MANAGEMENT S.A. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,108,110
-54.6%
611,018
+34.8%
0.02%
-63.0%
Q2 2023$11,262,456
+120.3%
453,400
+33.4%
0.05%
+91.7%
Q1 2023$5,112,096
+723.6%
339,900
+547.8%
0.02%
+500.0%
Q4 2022$620,720
-100.0%
52,470
+30.5%
0.00%
-55.6%
Q3 2021$1,337,856,000
+97.3%
40,200
+208.4%
0.01%
+50.0%
Q4 2020$678,028,00013,0340.01%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders